INFI · Categories · Form 4

INFI - SEC Form 4 insider transactions

Infinity Pharmaceuticals Inc. (INFI) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for INFI

• 995d
  SEC Form 4: Perkins Adelene Q converted options into 768,133 shares and sold $28,714 worth of shares (410,196 units at $0.07), increasing direct ownership by 44% to 1,175,291 units

  4 - INFINITY PHARMACEUTICALS, INC. (0001113148) (Issuer)
• 1399d
  SEC Form 4: Peluso Stephane converted options into 50,000 shares, increasing direct ownership by 1,711% to 37,052 units to cover taxes

  4 - INFINITY PHARMACEUTICALS, INC. (0001113148) (Issuer)
• 1448d
  SEC Form 4: Evnin Anthony B was granted 46,378 shares, increasing direct ownership by 27% to 215,403 units

  4 - INFINITY PHARMACEUTICALS, INC. (0001113148) (Issuer)
• 1448d
  SEC Form 4 filed by Beier David W

  4 - INFINITY PHARMACEUTICALS, INC. (0001113148) (Issuer)
• 1448d
  SEC Form 4 filed by Gaynor Richard

  4 - INFINITY PHARMACEUTICALS, INC. (0001113148) (Issuer)
• 1448d
  SEC Form 4 filed by Agresta Samuel

  4 - INFINITY PHARMACEUTICALS, INC. (0001113148) (Issuer)
• 1448d
  SEC Form 4 filed by Selby Norman C

  4 - INFINITY PHARMACEUTICALS, INC. (0001113148) (Issuer)
• 1448d
  SEC Form 4: Schwartz Brian was granted 30,919 shares

  4 - INFINITY PHARMACEUTICALS, INC. (0001113148) (Issuer)
• 1525d
  SEC Form 4 filed by Kango Sujay

  4 - INFINITY PHARMACEUTICALS, INC. (0001113148) (Issuer)
• 1603d
  SEC Form 4 filed by Perkins Adelene Q

  4 - INFINITY PHARMACEUTICALS, INC. (0001113148) (Issuer)
• 1603d
  SEC Form 4 filed by Peluso Stephane

  4 - INFINITY PHARMACEUTICALS, INC. (0001113148) (Issuer)
• 1603d
  SEC Form 4 filed by Tasker Seth A

  4 - INFINITY PHARMACEUTICALS, INC. (0001113148) (Issuer)
• 1603d
  SEC Form 4 filed by Bloch Lawrence E

  4 - INFINITY PHARMACEUTICALS, INC. (0001113148) (Issuer)
• 1603d
  SEC Form 4 filed by Ilaria Robert Jr.

  4 - INFINITY PHARMACEUTICALS, INC. (0001113148) (Issuer)
• 1727d
  SEC Form 4 filed by Schwartz Brian

  4 - INFINITY PHARMACEUTICALS, INC. (0001113148) (Issuer)
• 1734d
  SEC Form 4 filed by Ilaria Robert Jr.

  4 - INFINITY PHARMACEUTICALS, INC. (0001113148) (Issuer)
• 1765d
  SEC Form 4 filed by Peluso Stephane

  4 - INFINITY PHARMACEUTICALS, INC. (0001113148) (Issuer)
• 1818d
  SEC Form 4: BEIER DAVID W was granted 3,061 units of Common Stock, increasing direct ownership by 54% to 8,775 units

  4 - INFINITY PHARMACEUTICALS, INC. (0001113148) (Issuer)
• 1818d
  SEC Form 4 filed by Agresta Samuel

  4 - INFINITY PHARMACEUTICALS, INC. (0001113148) (Issuer)
• 1818d
  SEC Form 4 filed by SELBY NORMAN C

  4 - INFINITY PHARMACEUTICALS, INC. (0001113148) (Issuer)
• 1818d
  SEC Form 4 filed by GAYNOR RICHARD

  4 - INFINITY PHARMACEUTICALS, INC. (0001113148) (Issuer)
• 1818d
  SEC Form 4: EVNIN ANTHONY B was granted 3,061 units of Common Stock, increasing direct ownership by 2% to 169,025 units

  4 - INFINITY PHARMACEUTICALS, INC. (0001113148) (Issuer)
• 1930d
  SEC Form 4 filed by P/Il L Partners Bvf

  4 - INFINITY PHARMACEUTICALS, INC. (0001113148) (Issuer)
• 1954d
  SEC Form 4: P/Il L Partners Bvf sold $24,205,855 worth of Common Stock (5,848,520 units at $4.14)

  4 - INFINITY PHARMACEUTICALS, INC. (0001113148) (Issuer)

Other INFI categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends